Share
1,947 Posts.
lightbulb Created with Sketch. 272
clock Created with Sketch. 14/06/24
15:10
Share
Originally posted by FreshInvester:
↑
It goes both ways rampers 10 dollars is ridiculous at this stage so many hurdles left until we are profitable. Then there's the downies, realistically this coming 12 months multiple human trial results that are in probability positive (if not the BIT management have finally entered legal territory, missing deadlines is one thing giving false outcomes would be fraudulent). Current market cap is 40-50 million I think at least 200 million is fair if it shows any significant effect on HIV in this incoming study. Unfortunately confidence is so low not many will be willing to invest, if results are just above average. My prediction is somewhere in the middle results =>50% chance of being released as said by management (for the many reasons discussed already) SP =>50% chance of 10c-12c as historical price action has shown. Will it stay there, I don't know I think it will be a very quick rise and then quick profit taking by day traders. Results released, if they are not stellar 10c-12c within a week back down to 8-9.
Expand
hard one to value. On paper, any phase 2(b) hiv cure strategy company should have a significantly higher market cap than sub 50m.
